Morphotek

Monoclonal antibodies against cancer, inflammatory and infectious diseases.

placeExton, Pennsylvania, United States calendar_todayFounded 2000 groups104 employees language morphotek.com

Innovation

67 patent families (36 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 11,654 times.

YearFilings
201222
201321
201414
201520
201615
201719
201814
20193
20203
20213
20221
20231

Investor mix

23 investors on record; lead investors include Investor Growth Capital, AGTC Funds; 3 have since exited.

Investor typeCountShare
Venture capital1252%
Private equity14%
Other / undisclosed1043%
Coming soon